Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Alpha 2-adrenoceptor participates in anti-hyperalgesia by regulating metabolic demand

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The α2-adrenoceptor agonist dexmedetomidine is a commonly used drug for sedatives in clinics and has analgesic effects; however, its mechanism of analgesia in the spine remains unclear. In this study, we systematically used behavioural and transcriptomic sequencing, pharmacological intervention, electrophysiological recording and ultrasound imaging to explore the analgesic effects of the α2-adrenoceptor and its molecular mechanism. Firstly, we found that spinal nerve injury changed the spinal transcriptome expression, and the differential genes were mainly related to calcium signalling and tissue metabolic pathways. In addition, α2-adrenoceptor mRNA expression was significantly upregulated, and α2-adrenoceptor was significantly colocalised with markers, particularly neuronal markers. Intrathecal dexmedetomidine suppressed neuropathic pain and acute inflammatory pain in a dose-dependent manner. The transcriptome results demonstrated that the analgesic effect of dexmedetomidine may be related to the modulation of neuronal metabolism. Weighted gene correlation network analysis indicated that turquoise, brown, yellow and grey modules were the most correlated with dexmedetomidine-induced analgesic effects. Bioinformatics also annotated the involvement of metabolic processes and neural plasticity. A cardiovascular–mitochondrial interaction was found, and ultrasound imaging revealed that injection of dexmedetomidine significantly enhanced spinal cord perfusion in rats with neuropathic pain, which might be regulated by pyruvate dehydrogenase kinase 4 (pdk4), cholesterol 25-hydroxylase (ch25 h) and GTP cyclohydrolase 1 (gch1). Increasing the perfusion doses of dexmedetomidine significantly suppressed the frequency and amplitude of spinal nerve ligation-induced miniature excitatory postsynaptic currents. Overall, dexmedetomidine exerts analgesic effects by restoring neuronal metabolic processes through agonism of the α2-adrenoceptor and subsequently inhibiting changes in synaptic plasticity.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Methods Used to Evaluate Pain Behaviors in Rodents

          Rodents are commonly used to study the pathophysiological mechanisms of pain as studies in humans may be difficult to perform and ethically limited. As pain cannot be directly measured in rodents, many methods that quantify “pain-like” behaviors or nociception have been developed. These behavioral methods can be divided into stimulus-evoked or non-stimulus evoked (spontaneous) nociception, based on whether or not application of an external stimulus is used to elicit a withdrawal response. Stimulus-evoked methods, which include manual and electronic von Frey, Randall-Selitto and the Hargreaves test, were the first to be developed and continue to be in widespread use. However, concerns over the clinical translatability of stimulus-evoked nociception in recent years has led to the development and increasing implementation of non-stimulus evoked methods, such as grimace scales, burrowing, weight bearing and gait analysis. This review article provides an overview, as well as discussion of the advantages and disadvantages of the most commonly used behavioral methods of stimulus-evoked and non-stimulus-evoked nociception used in rodents.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells.

            Mutations in the human dynamin-related protein Drp1 cause mitochondria to form perinuclear clusters. We show here that these mitochondrial clusters consist of highly interconnected mitochondrial tubules. The increased connectivity between mitochondria indicates that the balance between mitochondrial division and fusion is shifted toward fusion. Such a shift is consistent with a block in mitochondrial division. Immunofluorescence and subcellular fractionation show that endogenous Drp1 is localized to mitochondria, which is also consistent with a role in mitochondrial division. A direct role in mitochondrial division is suggested by time-lapse photography of transfected cells, in which green fluorescent protein fused to Drp1 is concentrated in spots that mark actual mitochondrial division events. We find that purified human Drp1 can self-assemble into multimeric ring-like structures with dimensions similar to those of dynamin multimers. The structural and functional similarities between dynamin and Drp1 suggest that Drp1 wraps around the constriction points of dividing mitochondria, analogous to dynamin collars at the necks of budding vesicles. We conclude that Drp1 contributes to mitochondrial division in mammalian cells.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The CH25H–CYP7B1–RORα axis of cholesterol metabolism regulates osteoarthritis

              Osteoarthritis-the most common form of age-related degenerative whole-joint disease1-is primarily characterized by cartilage destruction, as well as by synovial inflammation, osteophyte formation and subchondral bone remodelling2,3. However, the molecular mechanisms that underlie the pathogenesis of osteoarthritis are largely unknown. Although osteoarthritis is currently considered to be associated with metabolic disorders, direct evidence for this is lacking, and the role of cholesterol metabolism in the pathogenesis of osteoarthritis has not been fully investigated4-6. Various types of cholesterol hydroxylases contribute to cholesterol metabolism in extrahepatic tissues by converting cellular cholesterol to circulating oxysterols, which regulate diverse biological processes7,8. Here we show that the CH25H-CYP7B1-RORα axis of cholesterol metabolism in chondrocytes is a crucial catabolic regulator of the pathogenesis of osteoarthritis. Osteoarthritic chondrocytes had increased levels of cholesterol because of enhanced uptake, upregulation of cholesterol hydroxylases (CH25H and CYP7B1) and increased production of oxysterol metabolites. Adenoviral overexpression of CH25H or CYP7B1 in mouse joint tissues caused experimental osteoarthritis, whereas knockout or knockdown of these hydroxylases abrogated the pathogenesis of osteoarthritis. Moreover, retinoic acid-related orphan receptor alpha (RORα) was found to mediate the induction of osteoarthritis by alterations in cholesterol metabolism. These results indicate that osteoarthritis is a disease associated with metabolic disorders and suggest that targeting the CH25H-CYP7B1-RORα axis of cholesterol metabolism may provide a therapeutic avenue for treating osteoarthritis.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/2575562/overviewRole: Role: Role: Role:
                Role: Role: Role:
                Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/533560/overviewRole: Role: Role: Role:
                Role: Role:
                URI : https://loop.frontiersin.org/people/2621685/overviewRole: Role: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/968810/overviewRole: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1238113/overviewRole: Role: Role:
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                21 March 2024
                2024
                : 15
                : 1359319
                Affiliations
                [1] 1 Department of Anesthesiology , Affiliated Shanghai Sixth People’s Hospital , Shanghai Jiao Tong University School of Medicine , Shanghai, China
                [2] 2 Shanghai Key Laboratory of Psychotic Disorders , Brain Health Institute , National Center for Mental Disorders , Shanghai Mental Health Center , Shanghai Jiao Tong University School of Medicine , Shanghai, China
                [3] 3 Department of Anesthesiology , Renji Hospital , Shanghai Jiao Tong University School of Medicine , Shanghai, China
                [4] 4 Shanghai Eye Disease Prevention and Treatment Center/Shanghai Eye Hospital , Department of Pharmacy , Shanghai, China
                [5] 5 Department of Orthopedics , The Fifth People’s Hospital of Shanghai , Fudan University , Shanghai, China
                Author notes

                Edited by: Weijie Xie, Tongji University, China

                Reviewed by: Khalil Ali Ahmad, University of Texas MD Anderson Cancer Center, United States

                Yang Hong Xu, Chinese Academy of Sciences (CAS), China

                Muhammad Usman, Western University, Canada

                *Correspondence: Jiao-Qiong Guan, eyjqguan@ 123456scut.edu.can ; Le Ma, male412810253@ 123456sjtu.edu.cn
                [ † ]

                These authors have contributed equally to this work and share first authorship

                Article
                1359319
                10.3389/fphar.2024.1359319
                10996398
                38584597
                cce2c3d5-9b52-4121-898b-5eb4497c62d0
                Copyright © 2024 Zhang, Ren, Xue, Duan, Zhou, Ding, Li, Gong, Guan and Ma.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 21 December 2023
                : 20 February 2024
                Funding
                The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study is supported by the Postdoctoral Science Foundation of China (2021M692118, W-JX; 2022M712126, W-KG; 2023M742355, GZC20231656, KZ) and Shanghai Mental Health Center (2021-YJ11 and 2023-YJ02).
                Categories
                Pharmacology
                Original Research
                Custom metadata
                Neuropharmacology

                Pharmacology & Pharmaceutical medicine
                α2-adrenoceptor,pain,transcriptome,cardiovascular-mitochondrial interaction,metabolic processes

                Comments

                Comment on this article